News

Merck Gets FDA Approval for Respiratory Treatment for Infants
The U.S. Food and Drug Administration has approved Merck's Enflonsia, a treatment to prevent respiratory syncytial virus lower respiratory tract disease in newborns and infants. The company said ...
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
healthdigest.com on MSN19m
An Experimental Treatment That Helped Cancer Patients Live 40% Longer Had One Noticeable Side Effect
A new immunotherapy for treating stomach cancer is helping people live 40% longer. However, some are affected by this ...
US FDA approves Merck's RSV antibody for infants
The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...